Clinical trials
Terminated Esophageal Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AHS Cancer Control Alberta | 1 |
| Adaptimmune | 1 |
| BioNTech SE | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Elevation Oncology | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| McMaster University | 1 |
| POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company | 1 |
| Pfizer | 1 |
| Seagen Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 13 |
| Neoplasm Metastasis | 5 |
| Stomach Neoplasms | 5 |
| Colorectal Neoplasms | 4 |
| Cholangiocarcinoma | 3 |
| Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Deglutition Disorders | 2 |
| Endometrial Neoplasms | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.